If you receive JavaScript required to sign in error message when using Skype, OneDrive, Teams or any other program, you need to turn on or enable JavaScript in your ...
WASHINGTON, DC – The Center for Strategic and International Studies (CSIS), a bipartisan, nonprofit policy research organization dedicated to advancing practical ideas to address the world’s greatest ...
Jun 23, 2026, 08:59 PM IST IST Navin Fluorine Intl. - Board Meeting Intimation for Inter-Alia, To Consider, Approve And Take On Record, The Unaudited Stand Jun 06, 2026, 12:48 AM IST IST Navin ...
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, ...
Navin Fluorine International Limited is an India-based company that is primarily focused on fluorine chemistry, which produces refrigeration gases, inorganic fluorides, specialty organofluorines. The ...
Navin Fluorine International Limited was incorporated on June 25, 1998. AS a flagship, Company belongs to a reputed industrial house of Padmanabh Mafatlal Group in India. It has largest integrated ...
Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services and Active ...
U.S. supplies of progesterone are coming under strain, with patients, clinicians, and pharmacists reporting recent intermittent shortages of oral versions of the hormone used in many fertility and ...
India's equity benchmarks logged their biggest monthly gains in seven months in October as strong corporate earnings and reasonable valuations drew in foreign investors. July 31, 2025 Indian shares ...
As a Psychiatric Nurse Practitioner based in Kansas, I am dedicated to providing compassionate, evidence-based mental health care for individuals across the lifespan — including developmental, adult, ...
Revenue from operations rose year-on-year by 16.45% at ₹701 crore from ₹602 crore in Q4 FY24.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results